Enoxparin is one a several formulations of LMWH. But I think it’s the most widely used.

Also unless your wife has lower extremity fractures this article doesn’t apply to her so she can rest easy.

So the two categories of “blood thinners” are anti platelets, and anticoagulants. Aspirin is in the former group, while drugs the article is talking about known as novel oral anticoagulants or NOACs include drugs like apixiban, dabigatran etc. in the latter.

If you have a fib something called a CHADS VAS score is used to determine your risk for a thromboembolic event and wether this outweighs bleed risk. If you have a CHADS VASC >2 in men or >3 in women then NOACs are superior to aspirin in preventing thromboembolism, although aspirin may still be used in addition to NOACs if you have say coronary artery disease.

However, at the moment standard of care for prevention of a recurrent stroke, is using dual anti plalet therapy (DAPT) clopidogrel + Asprin- see SAMPRIS trial.

So aspirin still can have its place but there’s a lot of nuance in deciding the medication regimen for someone.

No but it’s the first step. And it’s important because you need to make sure there’s actually increased aldosterone causing the hypertension because increased renin will do that as well (e.g. from renal artery stenosis). There’s several causes of secondary hypertension- it doesn’t always localize to the adrenal gland.

That’s for hypercortsolism causing Cushings disease.

You test for hyperaldosteronism with a aldosterone to renin ratio- done by blood draw